ABSTRACT Non-infectious uveitis is a major cause of visual loss, particularly among working-age adults. It is an intraocular inflammatory condition mediated by autoreactive T lymphocytes, and its severe forms may require therapies beyond corticosteroids. This article reviews recent advances in the treatment of the disease, emphasizing natural compounds and innovative ocular drug delivery systems, particularly those based on pharmaceutical nanotechnology. Compounds such as licarin A, lupeol, and melittin have shown promising anti-inflammatory and antiangiogenic properties in experimental models, with favorable […]
